This FOA invites applications for Clinical Centers to carefully characterize the normal course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs.
Clinical Centers will recruit and study pregnant women starting in the first trimester and
continuing at least through delivery.
A separate FOA (RFA-DK-18-019) will solicit a Biostatistics Research Center.
Each Clinical Center applicant will propose a study design and provide detailed information about recruitment capacity.
All awardees will form a cooperative research consortium in conjunction with NIDDK to design and implement a uniform protocol.
Information obtained from this study is expected to lead to improved approaches for screening for GDM, and inform the timing and approach for future clinical trials to decrease adverse perinatal outcomes and long-term sequelae of dysglycemia during pregnancy in both the mother and offspring.